In the present study, we verify the utility of CRISPR/Cas9 system in mechanistically studying lncRNAs by deleting UCA1, and verify UCA1 as an onco-lncRNA promoting bladder cancer progression. The gene discussed is UCA1; the disease is urinary bladder carcinoma.